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amount of intracellular apoptosis-associated speck-like pro-
tein containing a caspase-recruitment domain (ASC). The re-
duction of ASC was associated with enhanced autophago-
some formation and autophagic flux. Inhibition of autopha-
gy prevented the CoPP-induced depletion of ASC, implying 
that the depletion was caused by increased autophagy. Our 
data indicate that hemin functions as an endogenous nega-
tive regulator of the NLRP3 inflammasome. The inhibition is 
mediated via enhanced autophagy that results in increased 
degradation of ASC. This regulatory mechanism may pro-
vide a novel approach for the treatment of inflammasome-
related diseases.  © 2016 S. Karger AG, Basel 
 Introduction 
 Macrophages are important effector cells of the innate 
immune system, acting in the first line of defense by sens-
ing pathogens, cellular stress and tissue damage. Being 
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 Abstract 
 Inflammasomes are intracellular protein platforms, which, 
upon activation, produce the highly proinflammatory cyto-
kines interleukin (IL)-1β and IL-18. Heme, hemin and their 
degradation products possess significant immunomodula-
tory functions. Here, we studied whether hemin regulates 
inflammasome function in macrophages. Both hemin and its 
derivative, cobalt protoporphyrin (CoPP), significantly re-
duced IL-1β secretion by cultured human primary macro-
phages, the human monocytic leukemia cell line and also 
mouse bone marrow-derived and peritoneal macrophages. 
Intraperitoneal administration of CoPP to mice prior to urate 
crystal-induced peritonitis alleviated IL-1β secretion to the 
peritoneal cavity. In cultured macrophages, hemin and CoPP 
inhibited NLRP3 inflammasome assembly by reducing the 
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responsible for the degradation of damaged or senescent 
erythrocytes, they are central cells for heme and hemin 
catabolism and iron homeostasis  [1] . In response to dan-
ger signals, they secrete a myriad of proinflammatory cy-
tokines. Of these, interleukin (IL)-1β and IL-18 are syn-
thesized as precursor proteins, which need to be pro-
cessed to their mature secreted forms by cytosolic 
multiprotein complexes, called inflammasomes  [2] . In-
flammasomes are activated by a variety of endogenous 
and exogenous activators, such as adenosine triphosphate 
(ATP) released from damaged cells, cholesterol and urate 
crystals as well as bacterial toxins  [3–5] . The most studied 
inflammasome is the NLRP3 (nucleotide-binding do-
main and leucine-rich repeat containing family, pyrin do-
main containing 3). The NLRP3 inflammasome compris-
es the pattern recognition receptor NLRP3 and the adap-
tor protein ASC (apoptosis-associated speck-like protein 
containing a caspase-recruitment domain), which, upon 
activation, oligomerizes and recruits procaspase-1 into 
the inflammasome complex  [6] . The oligomerized ASC 
can be visualized as a large cytosolic ‘ASC speck’  [6] . As-
sembly of the inflammasome complex results in the auto-
cleavage-mediated activation of caspase-1, thereby ren-
dering it capable of cleaving pro-IL-1β and pro-IL-18 into 
their mature secreted forms  [2] .
 The activation of the NLRP3 inflammasome requires 
2 separate signals. A priming signal, mediated by the ac-
tivation of TLRs or cytokine receptors, induces the up-
regulation of the NLRP3 protein as well as the expression 
of pro-IL-1β  [7] . The second signal is required for the 
induction of inflammasome assembly and the activation 
of the inflammasome complex. The exact mechanisms of 
such activation by the structurally and chemically diverse 
agonists of the NLRP3 inflammasome are currently not 
known, but the process has been suggested to involve po-
tassium efflux, the production of reactive oxygen species 
(ROS), mitochondrial dysfunction and lysosomal desta-
bilization that results in the release of cathepsin B  [2] .
 Gain-of-function mutations of NLRP3, which result in 
excessive production of IL-1β, underlie the pathogenesis 
of cryopyrin-associated autoinflammatory diseases, such 
as Muckle-Wells syndrome  [3] . A role for enhanced 
NLRP3 inflammasome activity has also been implicated 
in the pathogenesis of some common disorders, such as 
gout, in which the urate crystals activate the NLRP3 in-
flammasome  [8] , and atherosclerosis  [4, 5] . Thus, it is ob-
vious that stringent control mechanisms of inflamma-
some activation are needed. In contrast to the myriad of 
described activators of the NLRP3 inflammasome, much 
less is known about its negative regulation. Endogenous 
proteins, such as card- and pyrin-only proteins have been 
shown to inhibit the assembly of the NLRP3 inflamma-
some  [9] . Several posttranslational modifications of in-
flammasome components also inhibit the assembly and 
activation of the NLRP3 inflammasome  [10] .
 Macroautophagy, hereafter referred to as autophagy, 
is a vesicular trafficking process that targets damaged or 
superfluous cellular proteins and organelles for degrada-
tion  [11] . Recently, autophagy was also shown to be ca-
pable of downmodulating the NLRP3 inflammasome ac-
tivation and secretion of IL-1β  [12–14] . Ubiquitinated 
inflammasome components are directed to autophago-
somes by sequestosome 1 (SQSTM1)  [13] and, subse-
quently, the fusion of autophagosomes with lysosomes 
results in the degradation of inflammasome components 
by lysosomal hydrolases  [11] . Furthermore, damaged mi-
tochondria, which are capable of promoting NLRP3 in-
flammasome activation, are constantly disposed of by au-
tophagy  [14] . However, the relationship between autoph-
agy and the inflammasome-induced secretion of IL-1β is 
complex. For example, despite the role of autophagy as a 
negative regulator of inflammasome activation, it has also 
been shown to be required for the secretion of IL-1β  [15] . 
 In this study, we identified a novel negative regulatory 
mechanism of the activation of the NLRP3 inflammasome. 
We show that hemin and its derivative, cobalt protopor-
phyrin (CoPP), strongly inhibit the secretion of IL-1β by 
depleting the intracellular levels of ASC, thus abolishing 
the formation of ASC specks. Hemin and CoPP reduce the 
amount of ASC by increasing the autophagy, and thereby 
direct ASC for degradation in autophagosomes. 
 Materials and Methods 
 Reagents 
 Lipopolysaccharide (LPS) from the  E. coli 0111:B4 strain (Ul-
traPure LPS) from InvivoGen (San Diego, Calif., USA) was used 
for the priming of mouse macrophages and LPS from Sigma (Saint 
Louis, Mo., USA) was used for the priming of human primary 
macrophages and THP-1 macrophages. CoPP, hemin and biliru-
bin were from Sigma and tin mesoporphyrin (SnMP) was from 
Santa Cruz (Dallas, Tex., USA). CoPP (150 m M ) and bilirubin
(5 m M ) were dissolved in DMSO, while hemin (5 m M ) and SnMP 
(10 m M ) were dissolved in 0.1  M NaOH, neutralized and sterile 
filtered. Tricarbonyldichlororuthenium (II) dimer was from Sig-
ma. The water-soluble carbon monoxide-releasing molecule 
tricarbonylchloro(glycinato)ruthenium(II) (CORM-3) was syn-
thesized as previously described by Clark et al.  [16] , and stored at 
–20   °   C as a lyophilisate. Nigericin sodium salt was from Sigma. 
Recombinant human apo-serum amyloid A (SAA) (isotype 1α), 
with an endotoxin level of <1 EU/μg protein, as determined by the 
manufacturer, was from Peprotech (Princeton, N.J., USA). Mono-
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sodium urate (MSU) crystals were prepared from uric acid (Sigma) 
as previously described  [17] , and stored at –20   °   C. The endotoxin 
level of the crystals was found to be below the detection limit (<0.03 
EU/ml) in the Pyrogent gel clot LAL assay (Lonza, Walkersville, 
Md., USA).
 Animals 
 All animal experiments were conducted in conformity with 
Finnish regulations and the protocols were approved by The
National Animal Experiment Board (permission No. ESAVI/
4690/04.10.07/2015). All mice were housed with 5–6 mice per cage 
in conditions controlled for light/dark cycle, temperature and hu-
midity. The mice had unlimited access to drinking water and food 
(standard chow: Teklad Global 16% protein rodent diet, Harlan 
Laboratories, Madison, Wis., USA or Altromin 1314 FORTI, 
breeding diet rats/mice, Lage, Germany). Wild-type (WT) 
C57BL/6J mice, used for in vivo experiments, were obtained from 
Harlan Laboratories, Venray, The Netherlands. HMOX1 fl/– mice 
(on a mixed C57BL/6.129/Sv background) were obtained from 
Biomedical Sciences Research Center ‘Alexander Fleming’ (Vari, 
Greece)  [18] . HMOX1 fl/– mice were further inbred to generate 
HMOX1 fl/fl mice. Myeloid cell-specific ablation of  Hmox1 was 
generated as follows: HMOX1 fl/fl mice were crossed with 
LysMCre +/+ mice (Jackson Laboratories, Bar Harbor, Maine, USA; 
B6.129P2- Lyz2 tm1(cre)Ifo /J, the mouse strain is backcrossed to 
C57BL/6 for at least 6 generations) that express cre-deleter in the 
cells of myeloid cell lineage  [19] . The LysMCre +/– HMOX1 fl/– mice 
obtained were backcrossed with HMOX1 fl/fl mice to generate 
LysMCre +/– HMOX1 fl/fl mice. Thioglycollate-elicited peritone-
al macrophages (TEPMs) were collected from LysMCre +/– 
HMOX1 fl/fl and littermate controls LysMCre –/– HMOX1 fl/fl . Prim-
er pairs used in genotyping are listed in  table 1 . 
 Cell Cultures 
 Human Primary Macrophages 
 Human mononuclear cells were isolated by density gradient 
centrifugation (800  g for 30 min) in Ficoll-Paque PLUS (GE 
Healthcare Life Sciences, Uppsala, Sweden) from fresh buffy coats 
supplied by the Finnish Red Cross Blood Service (Helsinki, Fin-
land). Buffy coats were obtained from healthy blood donors, after 
obtaining informed consent. The buffy coats were byproducts of 
the preparation of blood products for clinical use. The use of buffy 
coats in monocyte isolation was approved by the Finnish Red 
Cross Blood Service, Helsinki, Finland. Monocytes were allowed 
to adhere on cell culture wells, and nonadherent mononuclear cells 
were removed by washing with PBS w/o Ca 2+ and Mg 2+ . The ob-
tained monocytes were differentiated into macrophages using re-
combinant granulocyte macrophage colony-stimulating factor 
(GM-CSF, 10 ng/ml; Nordic Biosite, Täby, Sweden) in macro-
phage serum-free medium (Gibco/Life Technologies, Carlsbad, 
Calif., USA), supplemented with 100 U/ml penicillin and 100 μg/
ml streptomycin, as previously described  [20] . Each experiment 
with primary human macrophages was performed using macro-
phages derived from at least 4 donors.
 Human Monocytic Leukemia Cell Line Macrophages 
 The human monocytic leukemia cell line (THP-1) was pur-
chased from the American Type Culture Collection (ATCC, Cata-
log No. TIB-202, Manassas, Va., USA). Cells were maintained in 
RPMI 1640 supplemented with 2 m M  L -glutamine, 10% fetal bo-
vine serum, 25 m M HEPES, 100 U/ml penicillin and 100 μg/ml 
streptomycin (all from Lonza). Monocyte-to-macrophage differ-
entiation of THP-1 cells was induced by PMA (100 n M , 72 h) (Sig-
ma). In the experiments, only PMA-differentiated THP-1 cells, i.e. 
THP-1 macrophages, were used.
 Mouse Macrophages  
 Femoral and tibial bone marrow cells of WT mice were differ-
entiated into bone marrow-derived macrophages (BMDMs) in the 
presence of 50 ng/ml of macrophage colony-stimulating factor (M-
CSF, Nordic Biosite) in RPMI 1640 supplemented with 2 m M  L -
glutamine, 10% fetal bovine serum, 25 m M HEPES, 100 U/ml pen-
icillin, 100 μg/ml streptomycin and β-mercaptoethanol (Sigma) for 
7 days. For the collection of BMDMs, the mice were terminally 
anesthetized with isofluorane, and euthanasia was assured by cervi-
cal dislocation. Bone marrow was flushed with PBS, and erythro-
cytes were removed using red blood cell lysing buffer (Sigma). 
TEPMs were harvested from the peritoneal fluid 3 days after the 
injection of thioglycollate medium (2 ml) into the peritoneal cavity. 
The cells were plated in cell culture wells and allowed to adhere in 
the presence or absence of LPS (0.01 μg/ml, 3 h) as a priming factor, 
after which they were washed and used for the experiments. 
 MSU Peritonitis  
 WT female C57BL/6J (aged 8–13 weeks) mice were used for in 
vivo experiments. Before the experiments, the mice received bu-
prenorphine (0.1 mg/kg) subcutaneously for analgesia. Prior to the 
induction of peritonitis, they received intraperitoneal (i.p.) injec-
tion of CoPP (25 mg/kg in PBS, 300 μl/mouse) or PBS (300 μl/
mouse), followed by an i.p. injection of MSU crystals (3 mg in PBS, 
300 μl/mouse) or PBS (300 μl/mouse) 1 h later. Peritonitis was al-
lowed to develop for 20 h, after which the mice were terminally 
anesthetized by isoflurane, fully exsanguinated by cardiac punc-
ture, and the peritoneal cavity was lavaged with 2 ml of 0.1% BSA 
in PBS. The peritoneal fluid was centrifuged at 200  g for 5 min and 
the total cell counts were determined by using a Bürker chamber.
 Table 1.  Mouse genotyping primers for RT-PCR
Primer Sequence Source
HMOX1 F 5′-AGG GGA AGA AGA CTC ATC GA-3′ B.S.R.C. Alexander Fleming, Greece
HMOX1 R 5′-AGA AGG CTC GGA GGT TAA AT-3′ B.S.R.C. Alexander Fleming, Greece
LysM mutant 5′-CCC AGA AAT GCC AGA TTA CG-3′ The Jackson Laboratory
LysM common 5′-CTT GGG CTG CCA GAA TTT CTC-3′ The Jackson Laboratory
LysM wt 5′-TTA CAG TCG GCC AGG CTG AC-3′ The Jackson Laboratory
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 Inflammasome Activation in Cultured Macrophages 
 Briefly, to activate the NLRP3 inflammasome, macrophages 
were first primed with the TLR4 agonist LPS for 3 h. Different final 
concentrations of LPS were used: human primary macrophages 
and THP-1 macrophages (1 μg/ml), and mouse macrophages (0.01 
μg/ml). After priming, the cells were washed twice and incubated 
in the presence of the indicated concentrations of CoPP, hemin, 
CORM-3 or bilirubin (incubation times are given below). CoPP, 
hemin, CORM-3 and bilirubin were present during inflamma-
some activation.
 Activation of the NLRP3 Inflammasome  
 After LPS-primed macrophages were incubated for 3 h in the 
presence of the indicated concentrations of CoPP or hemin, ATP
(5 m M , 30 min) or nigericin (4 μ M , 1 h) was added. To examine the 
effect of carbon monoxide, the LPS-primed human primary macro-
phages or THP-1 macrophages were incubated for 1 h in the pres-
ence of the indicated concentrations of CORM-3, after which ATP 
was added (5 m M , 30 min). The LPS-primed THP-1 macrophages 
were incubated in the presence of the indicated concentrations of 
bilirubin (20 min) and activated with ATP (5 mM , 30 min). SAA was 
used for both the priming and activation of the NLRP3 inflamma-
some  [21] . Macrophages were incubated in the presence of CoPP or 
hemin for 1 h prior to the addition of SAA (THP-1 macrophage ac-
tivation: 3 μg/ml, 5 h; BMDM activation: 2 μg/ml, 18 h; human pri-
mary macrophage activation: 3 μg/ml, 18 h). LPS-primed BMDMs 
were incubated in the presence of CoPP or hemin for 1 h prior to the 
addition of MSU crystals (250 μg/ml, 18 h). The enzymatic inhibitor 
of heme oxygenase-1 (HO-1), SnMP (5 μ M ), was administered to 
THP-1 macrophages 3 h prior to CoPP, and an inhibitor of autoph-
agy, 3-methyl adenine (3-MA, 5 m M ; Calbiochem, San Diego, Calif., 
USA), was added to the THP-1 macrophages 23 h prior to CoPP.
 Measurement of Cell Death  
 Trypan blue stain (0.2% w/v, 2 min) was routinely used to eval-
uate cell death. Cytotoxicity detection kit (Roche, Mannheim, Ger-
many) based on the determination of lactate dehydrogenase 
(LDH) release was used according to the manufacturer´s protocol. 
 ELISA Assays 
 IL-1β and IL-18 concentrations in cell culture medium and IL-
1β concentration from mouse peritoneal lavage were determined 
by using commercial sandwich ELISA assays (IL-1β assay by R&D 
Systems, Minneapolis, Minn., USA; IL-18 assay by Medical and 
Biological Laboratories, Nagoya Aichi, Japan) according to the 
manufacturer’s instructions.
 Quantitative Real-Time RT-PCR 
 The quantitative real-time RT- PCR protocol used has been 
described previously  [22] . The gene-specific primers and probes 
are given in  table 2 .
 Immunoblot Analysis  
 Cell culture media were concentrated using Vivaspin 6 cen-
trifugal concentrator with a 5-kDa cut-off (Sartorius, Göttingen, 
Germany). Adherent cells were collected and lysed in buffer con-
taining 250 m M sucrose and 1 m M EDTA and supplemented with 
1× protease inhibitor cocktail, pH 7.0 (Roche, Mannheim, Ger-
many). Proteins of cell lysates or concentrated medium samples 
were resolved by SDS-PAGE, and transferred to a PVDF mem-
brane (Millipore, Billerica, Mass., USA). PVDF membranes were 
incubated o/n at 4   °  C with antibodies raised against human IL-1β 
(proform detection: Santa Cruz Biotechnology; mature form de-
tection: Cell Signaling, Danvers, Mass., USA), caspase-1 (Adipo-
Gen, San Diego, Calif., USA), HO-1 (Santa Cruz Biotechnology), 
SQSTM1 (Santa Cruz Biotechnology), light chain 3 (LC3; Novus 
Biologicals, Littleton, Colo., USA), ASC (MBL international, Wo-
 Table 2.  Primers and probes for quantitative real-time RT-PCR
Primer/probe Sequence Source
Human
GAPDH F 5′-CCACATCGCTCAGACACCAT-3′ our laboratory
GAPDH R 5′-GGCAACAATATCCACTTTACCAGAG-3′ our laboratory
GAPDH fluorogenic probe 5′-FAM-CCAATACGACCAAATCCGTTGACTCC-BHQ1-3′ our laboratory
HMOX1 F 5′-TCCTGCTCAACATCCAGCTC-3′ our laboratory
HMOX1 R 5′-GGGCAGAATCTTGCACTTTG-3′ our laboratory
IL1B F 5′-TTACAGTGGCAATGAGGATGAC-3′ our laboratory
IL1B R 5′-GTCGGAGATTCGTAGCTGGAT-3′ our laboratory
IL1B fluorogenic probe 5′-FAM-AACAGATGAAGTGCTCCTTCCAGGACC-BHQ1-3′ our laboratory
NLRP3 F 5′-GGAGAGACCTTTATGAGAAAGCAA-3′ our laboratory
NLRP3 R 5′-GCTGTCTTCCTGGCATATCACA-3′ our laboratory
NLRP3 fluorogenic probe 5′-FAM-ACGTGCATTATCTGAACCCCACTTCGG-BHQ1-3′ our laboratory
Mouse
HMOX1 F 5′-CCTCACTGGCAGGAAATCATC-3′ [23]
HMOX1 R 5′-CCTCGTGGAGACGCTTTACATA-3′ [23]
18S Applied
Biosystems
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burn, Mass., USA) and β-actin (Abcam, Cambridge, UK). HRP-
conjugated polyclonal goat-anti-mouse and rabbit-anti-goat anti-
bodies (Dako, Glostrup, Denmark) were used as secondary anti-
bodies. The band intensities were quantified by Bio-Rad ChemiDoc 
MP imaging system (USA). The band intensities were normalized 
to the intensity of β-actin bands, except for the intensity of LC3-II 
bands, which were compared to the intensity of LC3-I bands by 
calculating the LC3-II/LC3-I ratio. 
 Cathepsin B/L activity measurement 
 Nigericin- and SAA-induced release of cathepsin B from lyso-
somes  [21, 24] was assessed as previously described  [22] . Briefly, 
LPS-primed THP-1 macrophages were incubated in the presence of 
2.5 μ M CoPP for 3 h, after which nigericin was added (4 μ M , 1 h). 
When SAA was used as the activator, THP-1 macrophages were in-
cubated in the presence of CoPP (2.5 μ M , 1 h) and then activated with 
SAA (3 μg/ml, 5 h). Cathepsin B/L-dependent hydrolysis of the flu-
orogenic substrate Z-Phe-Arg-AMC (Enzo Life Sciences, Farming-
dale, N.Y., USA) (40 μ M ) in the medium was measured (excitation 
at 355 nm, emission at 486 nm) after 1 h of incubation at 37  °  C.
 Immunofluorescence Microscopy 
 ASC speck detection was performed as previously described 
 [22] . Briefly, THP-1 macrophages were incubated in the presence 
of CoPP (2.5 μ M ) or hemin (5 μ M ) for 3 h before the addition of 
the NLRP3 inflammasome activator, nigericin (4 μ M , 1 h). PFA-
fixed cells were stained with anti-ASC antibody (MBL Interna-
tional), goat-anti-mouse IgG1 Alexa Fluor 488 (Invitrogen, Eu-
gene, Oreg., USA) was used as secondary antibody and the nuclei 
were stained with DAPI. The speck formation was quantified by 
epifluorescence microscopy. The number of specks/field were di-
vided by the number of cells/field, and expressed as percentages; 
10 different fields (on average 200 cells/field) were counted in each 
of the 4 experiments.
 For the SQSTM1/ASC double-immunofluorescence staining, 
THP-1 macrophages were incubated in the presence of CoPP
(5 μ M ) for 2 or 4 h. PFA-fixed cells were stained with antibodies 
for ASC (Adipogen, San Diego, Calif., USA) and SQSTM1 (Santa 
Cruz Biotechnology). Goat-anti-rabbit IgG (H+L) Alexa Fluor 594 
for ASC and goat-anti-mouse IgG1 Alexa Fluor 488 for SQSTM1 
(both from Invitrogen) were used as secondary antibodies. The 
nuclei were stained with DAPI.
 Measurement by Inductively Coupled Plasma Mass 
Spectrometry  
 THP-1 macrophages were incubated in the presence of CoPP 
(2.5 μ M , 3 h), after which the NLRP3 inflammasome was activated 
with nigericin (4 μ M , 1 h). Analysis of intracellular potassium con-
centration was performed by inductively coupled plasma mass 
spectrometry (ICP-MS) as previously described  [22] . Briefly, 
THP-1 macrophages from 6 parallel wells were lysed in 70% nitric 
acid (Romil-SpA, Cambridge, UK), and the potassium concentra-
tion was determined according to ISO 17294-2  [25] in helium 
mode (Agilent 7500 ce/cx ICP-MS, Alpharetta, Ga., USA). Analy-
ses were performed at the Department of Geosciences and Geog-
raphy, University of Helsinki. Elemental recovery of 101% was 
measured using the National Institute of Standards and Technol-
ogy standard as the reference (NIST-1577C, Gaithersburg, Md., 
USA).
 ROS Generation Assays 
 To analyze cytosolic ROS formation, THP-1 macrophages were 
incubated in the presence of hemin (5 μ M ) or CoPP (5 μ M ) for 1 or 
3 h, after which the cells were stimulated with nigericin or left non-
stimulated (4 μ M , 1 h). Before the measurement, the cells were 
washed and incubated for 30 min at 37  °  C in 5% CO 2 in PBS with 
Ca 2+ and Mg 2+ containing 50 μ M dihydrorhodamine 123 (DHR 
123) (Sigma), hemin or CoPP, and nigericin. The cells were lysed 
in 200 μl of 1% TritonX and the fluorescence was measured im-
mediately with a plate reader (Hidex Plate Chameleon 5, Turku, 
Finland), with excitation at 500 nm and emission at 536 nm.
 To assess the accumulation of mitochondrial ROS, THP-1 
macrophages were incubated in the presence of hemin (5 μ M ) or 
CoPP (5 μ M ) for 1 or 2 h, and then stimulated with nigericin or left 
unstimulated (4 μ M , 1 h). Before detachment, the cells were washed 
and incubated for 30 min at 37  °  C in 5% CO 2 in PBS with Ca 2+ and 
Mg 2+ containing 5 μ M mitoSOX (Molecular Probes, Eugene, Oreg., 
USA), hemin or CoPP, and nigericin. The cells were washed, incu-
bated with trypsin (0.25%) for 5 min at 37   °   C and detached by 
gentle pipetting, which required an average of 1 h. At the time 
point of the measurement, the cells had been incubated in the pres-
ence of CoPP and hemin for 2 or 4 h. The detached cells were re-
suspended in cold PBS w/o Ca 2+ and Mg 2+ containing 1% FBS and 
the mitochondrial ROS were measured by flow cytometry (BD Ac-
curi, San José, Calif., USA; 10 000 events counted in each measure-
ment) and the results were analyzed by FlowJo v10.
 Statistical Analysis 
 Statistical analyses were performed using GraphPad Prism v6 for 
Windows. Statistical differences between groups were identified us-
ing one-way analysis of variance (ANOVA) followed by the Tukey, 
Dunnett or Holm-Sidak multiple comparisons tests when appropri-
ate. Nonnormally distributed data was log 2 -transformed before sta-
tistical testing, and is indicated in the figure legends. Data are pre-
sented as means ± standard deviation (SD) of data from  ≥ 3 inde-
pendent experiments.
Fig. 1. CoPP and hemin inhibit the secretion of IL-1β by human 
and mouse macrophages. Unprimed or LPS-primed mouse
BMDMs were incubated for 3 h ( a ,  c ) or 1 h ( b ,  d ) in the presence 
of CoPP or hemin. The NLRP3 inflammasome was then activated 
with ATP ( a ), SAA ( b ), nigericin (Nig;  c ) and MSU crystals ( d ), 
and the secretion of mature IL-1β was measured by ELISA. 
Unprimed or LPS-primed human primary macrophages were in-
cubated for 3 h ( e ) or 1 h ( f ) in the presence of CoPP or hemin. 
Thereafter, the stimulation of the NLRP3 inflammasome was in-
duced by ATP ( e ) or SAA ( f ).  g THP-1 macrophages were incu-
bated for 3 h in the presence of CoPP or hemin, and thereafter 
activated with nigericin. Secretion of mature IL-1β was measured 
by ELISA, and is expressed as fold changes compared to the acti-
vated cells. Data represent the means ± SD of 3 ( c ), 4 ( a ,  b ,  d ,  f ,  g ) 
and 6 ( e ) individual experiments.  a–g Statistical significance was 
evaluated with log 2 -transformed values.  *  p ≤ 0.05;  * *  p ≤ 0.01; 
 * * *  p ≤ 0.001;  ****  p ≤ 0.0001.
(For figure see next page.)
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 Fig. 2. CoPP and hemin inhibit inflammasome activation. Cleav-
age of pro-IL-1β (35 kDa) to mature IL-1β (17 kDa) and of procas-
pase-1 (45 kDa) to active caspase-1 (20 kDa) were assessed from 
Western blots of the cell culture media. THP-1 macrophages were 
incubated for 3 h in the presence of CoPP or hemin ( a ,  c ) or for
1 h in the presence of CoPP ( b ,  d ), after which, nigericin (Nig;  a , 
 c ) or SAA ( b ,  d ) was added. The Western blots presented are rep-
resentative of at least 4 individual experiments.  e ,  f Mice were
injected i.p. with CoPP (25 mg/kg) or vehicle (PBS) 1 h before
challenge with MSU crystals. Peritonitis was allowed to develop for 
20 h, after which, the peritoneal cavities of the mice were lavaged. 
 e IL-1β concentration was measured by ELISA and cell numbers 
( f ) were counted from the peritoneal lavage fluid. ** p ≤ 0.01. Each 
data point in  e and  f represents 1 mouse; statistical significance was 
evaluated with log 2 -transformed values. Data represent the means 
± SD.  
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 Results 
 Hemin and CoPP Reduce the Secretion of IL-1β by 
Mouse and Human Macrophages 
 Mouse BMDMs, human primary macrophages or 
THP-1 macrophages were incubated in the presence of 
hemin or CoPP, after which the NLRP3 inflammasome 
was activated with ATP, SAA, MSU crystals or nigericin. 
As demonstrated in  figure 1 , the secretion of IL-1β, in-
duced by different NLRP3 inflammasome activators, was 
significantly reduced in the presence of hemin or CoPP, 
in both mouse ( fig. 1 a–d) and human ( fig. 1 e, f) macro-
phages. A similar inhibitory effect was also observed in 
the THP-1 macrophages ( fig. 1 g). It should be noted that 
THP-1 macrophages were more sensitive to the inhibi-
tory effect of CoPP and hemin and mouse BMDMs to the 
effect of CoPP when compared to human primary mac-
rophages. 
 The IL-1β ELISA results were confirmed by Western 
blot studies, which showed reduced secretion of the ma-
ture form (17 kDa) of IL-1β ( fig.  2 a, b; online suppl. 
fig.  1A–C; for all online suppl. material, see www.
karger.com/doi/10.1159/000448894) and processed ac-
tive form (20 kDa) of caspase-1 ( fig. 2 c, d; online suppl. 
fig. 1D–F) in the THP-1 macrophages in the presence of 
hemin or CoPP. The incubation of the cells in the pres-
ence of CoPP or hemin had no effect on cell viability (on-
line suppl. fig. 1G, H). Inhibition of the NLRP3 inflam-
masome by CoPP was also evident in vivo ( fig. 2 e). Thus, 
i.p. injection of CoPP 1 h prior to induction of peritonitis 
by i.p. administration of MSU crystals significantly re-
duced the secretion of IL-1β into the peritoneal cavity. 
Pretreatment with CoPP also tended to diminish leuko-
cyte influx into the peritoneal cavity, but the reduction 
was not statistically significant ( fig. 2 f). 
 Hemin and CoPP Do Not Interfere with the Priming 
of the NLRP3 Inflammasome 
 Before NLRP3 inflammasome can be activated, a sepa-
rate priming step is required during which the expression 
of NLRP3 receptor and the proform of IL-1β are induced 
 [7] . So next, we studied whether hemin and CoPP re-
duced IL-1β secretion by inhibiting the priming step. For 
this purpose, human primary macrophages were primed 
via the activation of TLR4 with LPS and were then treated 
with hemin or CoPP. Treatment with both compounds 
did not reduce the expression of  IL1B or  NLRP3  ( fig. 3 a, 
b). Likewise, no reduction was observed in the expression 
of  IL1B or  NLRP3 in THP-1 macrophages (online suppl. 
fig. 1I, J). On the contrary, CoPP and hemin rather en-
hanced the expression of  IL1B in human primary macro-
phages. The LPS-induced expression of NLRP3 is known 
to be transient  [5, 7] and thus, at the time point of the 
measurement, the expression had already returned to 
baseline. These results are in agreement with the results 
obtained from Western blots of cell lysates from THP-1 
macrophages, showing that neither CoPP nor hemin had 
any significant effect on the intracellular protein levels
of procaspase-1 or pro-IL-1β ( fig.  3 c, d; online suppl. 
fig. 2A–F). However, a slight reduction in protein levels 
of intracellular NLRP3 was observed in the CoPP-treated 
THP-1 macrophages. Furthermore, hemin and CoPP 
also reduced the secretion of the mature IL-18 in the 
THP-1 macrophages ( fig.  3 e), the proform of which is 
constitutively expressed in these cells, and so priming is 
not required for its secretion  [26] . The data above indicate 
that the inhibition of IL-1β secretion by hemin or CoPP 
is not caused by the inhibition of the priming step, but 
instead by that of NLRP3 inflammasome activation.
 CoPP Inhibits Release of Cathepsin B and Production 
of Mitochondrial ROS but Has No Effect on Potassium 
Efflux 
 The intracellular events upstream of NLRP3 inflam-
masome activation include potassium efflux, leakage of 
lysosomal protease cathepsin B and ROS formation. The 
effect of CoPP on the potassium efflux was assessed by 
measuring the concentration of cellular potassium using 
ICP-MS. Activation of the NLRP3 inflammasome in 
THP-1 macrophages with nigericin significantly de-
creased the intracellular potassium concentration in the 
treated cells ( fig. 4 a). However, preincubation of the cells 
in the presence of CoPP had no impact on the intracel-
lular potassium concentration, in either the nigericin-ac-
tivated or nonactivated THP-1 macrophages. 
 Release of cathepsin B from intact lysosomes during 
nigericin- or SAA-induced activation is closely associated 
with the activation of the NLRP3 inflammasome  [21, 24] . 
The release of lysosomal cathepsins into cell culture me-
dium has been shown to accompany the secretion of ma-
ture IL-1β  [15] . Both nigericin and SAA induced a robust 
release of enzymatically active cathepsin B into the cell 
culture medium from the THP-1 macrophages, which 
was significantly inhibited by CoPP ( fig. 4 b, c). The mech-
anisms needed for the secretion of IL-1β are not explic-
itly known, but autophagy-driven secretion of IL-1β, dur-
ing which IL-1β is released from autophagosomal com-
partments, has been suggested  [15] . It is therefore possible 
that the reduced release of active cathepsin B from CoPP-
treated cells reflected the diminished secretion of IL-1β 
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and the inflammasome components from the autolyso-
somes rather than the impairment of cathepsin B-depen-
dent NLRP3 inflammasome activation. 
 Mitochondrial ROS has been implicated in the activa-
tion of the NLRP3 inflammasome  [14] . To assess the ef-
fect of hemin and CoPP on mitochondrial superoxide 
generation, a fluorogenic probe (mitoSOX), which spe-
cifically detects mitochondrial superoxide, was used. He-
min and CoPP alone had no effect on the generation of 
mitochondrial ROS compared to the nontreated cells, but 
inflammasome activation by nigericin induced a robust 
accumulation of mitochondrial ROS ( fig. 4 d, e). Impor-
tantly, the incubation of cells with hemin or CoPP prior 
to the inflammasome activation reduced the accumula-
tion of mitochondrial ROS. 
 Heme and hemin are pro-oxidant molecules that have 
been shown to induce ROS formation by nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase in 
macrophages  [27] . To determine the effect of hemin and 
CoPP on cytosolic ROS formation, we assessed the fluo-
rescence intensity of DHR 123 staining in nonstimulated 
and nigericin-stimulated THP-1 macrophages. DHR123 
detects cytosolic ROS species generated via NADPH oxi-
dase activation, among other sources. In both stimulated 
and nonstimulated THP-1 macrophages, the generation 
of ROS was increased by hemin and, to a lesser extent, 
with CoPP when compared to nontreated cells ( fig. 4 f). 
Taken together, the reduced accumulation of mitochon-
drial ROS by hemin and CoPP could have contributed to 
their inhibitory effect on nigericin-induced NLRP3 in-
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 Fig. 3. Hemin and CoPP do not inhibit priming of NLRP3 inflam-
masome.  a ,  b Unprimed or LPS-primed human primary macro-
phages were incubated for 3 h in the presence of CoPP and hemin. 
LPS-induced expression of  IL1B ( a ) and  NLRP3 ( b ) mRNA was 
determined by quantitative real-time RT-PCR. The gene expres-
sion is expressed as arbitrary units (a.u.).  c ,  d THP-1 macrophages 
were incubated for 3 h in the presence of CoPP ( c ) and hemin ( d ), 
and activated with nigericin (Nig.). The intracellular levels of 
NLRP3 (108 kDa), procaspase-1 (45 kDa) and pro-IL-β (37 kDa) 
were assessed from Western blots of the cell lysates. The Western 
blots shown are representatives of 4 individual experiments.  e To 
assess the secretion of active IL-18, THP-1 macrophages were in-
cubated for 3 h in the presence of CoPP or hemin, after which, the 
cells were activated with nigericin.  * * *  p ≤ 0.001;  * * **  p ≤ 0.0001. 
The secretion of IL-18 was measured by ELISA. Data represent the 
means ± SD of 3 ( e ) and 4 ( a ,  b ) individual experiments. 
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flammasome activation whereas their effect on NADPH 
oxidase-generated ROS is a less probable mechanism for 
the inhibition. 
 Inhibition of NLRP3 Inflammasome by Hemin and 
CoPP Is Partially Dependent on Heme Oxygenase-1  
 Since heme/hemin and CoPP are well-established in-
ducers of the heme-catabolizing antioxidant enzyme 
HO-1  [28] , we next studied whether the inhibitory effect 
of hemin and CoPP on NLRP3 inflammasome activation 
could be mediated via the induction of HO-1. Hemin and 
CoPP induced HO-1 protein expression during the first 
4 h after their addition to the THP-1 macrophages ( fig. 5 a; 
online suppl. fig. 2G), and a more robust expression was 
observed later at the 8-hour and 16-hour time points. 
Stannous mesoporphyrin (SnMP), a competitive inhibi-
tor of HO-1 enzymatic activity  [28] , strongly reversed the 
CoPP-induced inhibition of IL-1β secretion ( fig. 5 b). Fur-
thermore, of the products of heme/hemin degradation, 
carbon monoxide, but not bilirubin, attenuated the secre-
tion of IL-1β ( fig. 5 c; online suppl. fig. 2H, I). 
 The role of HO-1 as an endogenous inhibitor of the 
NLRP3 inflammasome was further studied in TEPMs ob-
tained from mice carrying a myeloid cell line-targeted de-
letion of  Hmox1 (LysMCre +/– HMOX1 fl/fl ). A trend of re-
duced  Hmox1 expression was observed in the HO-1-de-
 Fig. 4. Hemin and CoPP inhibit the release of cathepsin B and the 
generation of mitochondrial ROS.  a THP-1 macrophages were in-
cubated in the presence of CoPP for 3 h and activated with nigericin 
(Nig.). The potassium level of the cell lysates was determined by 
ICP-MS.  b ,  c Unprimed or LPS-primed THP-1 macrophag-
es were incubated in the presence of CoPP for 3 h ( b ) or 1 h ( c ) be-
fore the NLRP3 inflammasome was activated with nigericin ( b ) or 
SAA ( c ), and the release of active lysosomal proteases was detect-
ed by measuring the cleavage of cathepsin B/L substrate (excita-
tion at 355 nm, emission at 486 nm) in the cell culture medium. 
 d–f THP-1 macrophages were incubated in the presence of CoPP 
or hemin for the indicated times and activated with nigericin.
 d ,  e The cells were stained with mitoSOX (30 min), detached and 
analyzed by flow cytometry. Control (Cntr) cells represent the non-
treated cells stained with mitoSOX.  d The flow cytometric analysis 
shown is representative of 4 individual experiments.  e Fold chang-
es of mean fluorescence of flow cytometric analyses.  f THP-1 mac-
rophages were stained with DHR 123, and the fluorescence from 
cell lysates was analyzed by plate reader (excitation at 500 nm, emis-
sion at 536 nm). Given time points indicate the time passed from 
the administration of CoPP or hemin at the time point of the mea-
surement (see Materials and Methods). Data represent the means 
± SD of 3 ( a ), 4 ( e ) or 6 ( b ,  c ,  f ) individual experiments.  *  p ≤ 0.05; 
 * *  p ≤ 0.01;  * **  p ≤ 0.001;  ** * *  p ≤ 0.0001. 
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 Fig. 5. Inhibition of HO-1 enzymatic activ-
ity reverses the effect of CoPP. The expres-
sion of HO-1 protein induced by CoPP or 
hemin in THP-1 macrophages was deter-
mined at 4, 8 and 16 h.  a THP-1 macro-
phages were incubated in the presence of 
CoPP or hemin for the indicated times, and 
HO-1 (32 kDa) was assessed from the cell 
lysates by Western blot (representative of 4 
individual experiments).  b The enzymatic 
activity of HO-1 was inhibited by stannous 
mesoporphyrin (SnMP) for 3 h, prior to
the treatment of THP-1 macrophages with 
CoPP (3 h), after which, the cells were ac-
tivated with nigericin (Nig).  * *   p ≤ 0.01.
 c Unprimed or LPS-primed human prima-
ry macrophages were incubated for 1 h in 
the presence of CORM-3 or its inactivated 
form (iCORM-3), and thereafter activated 
with ATP. The secretion of IL-1β was mea-
sured by ELISA; statistical significance was 
evaluated with log 2 -transformed values. 
 *  p ≤ 0.05;  * * p ≤ 0.01. Data represent the 
means ± SD of 3 ( b ) or 5 ( c ) individual ex-
periments. 
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ficient TEPMs, whether nonactivated or nigericin-ac-
tivated (online suppl. fig. 2J). However, the reduction was 
not statistically significant. Elevated secretion of IL-1β 
was observed in the nigericin-activated TEPMs of HO-
1-deficient mice compared to TEPMs derived from the 
WT littermates (LysMCre –/– HMOX1 fl/fl ), supporting the 
hypothesis that HO-1 can function as an endogenous
regulator of the NLRP3 inflammasome (online suppl. 
fig. 2K). 
 The inhibitory effect of CoPP and hemin on the secre-
tion of IL-1β by the HO-1-deficient TEPMs was compa-
rable with the inhibition observed in the TEPMs derived 
from the WT littermates (online suppl. fig.  2K). These 
results argue against the hypothesis proposing a role for 
CoPP- and hemin-induced HO-1 as a mechanism of 
NLRP3 inflammasome inhibition. However, it should be 
noted that CoPP and hemin treatment was able to in-
crease  Hmox1 expression, also in the HO-1- deficient 
TEPMs (online suppl. fig. 2J). Altogether, the data above 
suggest that induction of HO-1 may contribute to the in-
hibitory effect of hemin and CoPP. Nevertheless, due to 
the limitations of the HO-1-deficient mouse model, i.e. 
the deletion of  Hmox1 in TEPMs was not complete, such 
a role for HO-1 could not be ascertained. 
 Hemin and CoPP Inhibit Inflammasome Complex 
Formation by Depleting Intracellular ASC 
 To further elucidate the mechanism by which CoPP 
and hemin inhibit inflammasome function, we studied 
their effect on the assembly of the NLRP3 inflammasome. 
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 Fig. 6. Hemin and CoPP block ASC speck formation.  a ,  b THP-1 
macrophages were incubated for 3 h in the presence of CoPP or 
hemin, and activated with nigericin (Nig.). Speck formation was 
visualized by staining for ASC (green) and DNA (blue, DAPI).
 a Representative of 4 individual experiments.  b The extent of speck 
formation was determined by dividing the number of the specks 
by the number of nuclei per field. Statistical significance was eval-
uated with log2-transformed values. Data represent the means ± 
SD of 4 individual experiments.  * * * *  p ≤ 0.0001.  c–f THP-1 mac-
rophages were incubated in the presence of CoPP ( c, e ) or hemin 
( d ,  f ) and activated with nigericin. Western blots of ASC (22 kDa) 
( c ,  d ) of the cell lysates and medium ( e ,  f ). Western blots shown 
are representative of 4 ( c–e ) or 5 ( f ) individual experiments. 
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The adaptor protein ASC is an obligatory mediator of 
molecular interactions between the receptor protein and 
procaspase-1 of the NLRP3 inflammasome  [3] . Upon in-
flammasome activation, ASC-dimers aggregate and form 
large structures called ASC specks or ASC foci, typically 
1 speck/cell  [6] . Nigericin induced a robust formation of 
ASC specks in THP-1 macrophages ( fig. 6 a, b). The incu-
bation of THP-1 macrophages in the presence of hemin 
or CoPP prior to the nigericin-induced activation of the 
NLRP3 inflammasome not only abolished the speck for-
mation but also dramatically reduced the level of ASC 
staining in the cytoplasm ( fig. 6 a). The reduction of the 
amount of intracellular ASC was further confirmed by 
Western blots of the cell lysates, which demonstrated that 
incubation of THP-1 macrophages in the presence of 
CoPP or hemin reduced the amount of ASC both in non-
activated and nigericin-activated cells ( fig. 6 c, d; online 
suppl. fig. 3A, B). 
 A relatively low mRNA expression of endogenous ASC 
(on average Ct 26.9) was detected in THP-1 macrophages, 
and it could not be significantly induced by nigericin. 
Moreover, the treatment of THP-1 macrophages with 
CoPP or hemin had no significant impact on the expres-
sion of  ASC  mRNA (online suppl. fig. 3C). A robust re-
lease of ASC protein in the cell culture medium was ob-
served in nigericin-activated THP-1 macrophages ( fig. 6 e, 
f; online suppl. fig.  3D, E). However, the nigericin-in-
duced release of ASC was significantly diminished in cells 
pretreated with CoPP or hemin. These data suggest that 
the reduction of ASC was not due to the diminished gene 
expression of  ASC  or the increased secretion of ASC. 
Rather, the data support the idea that hemin and CoPP 
disrupt the inflammasome speck formation by reducing 
the amount of intracellular ASC. 
 Hemin and CoPP Inhibit NLRP3 Activation by 
Enhancing Autophagy  
 The induction of autophagy has been shown to result 
in the degradation of inflammasome components  [12, 13] . 
Therefore, we next studied whether the degradation of 
ASC could be mediated via the induction of autophagy by 
hemin or CoPP. Microtubule-associated protein 1 light 
chain 3 (LC3) is an integral membrane protein of autoph-
agic vesicles, which is required for the formation of au-
tophagosomes  [29] . An increased ratio of LC3-II to LC3-I 
has been shown to correlate with increased formation of 
autophagosomes  [29] . In unprimed and LPS-primed hu-
man primary macrophages and THP-1 macrophages, 
CoPP increased the ratio of LC3-II to LC3-I in cells chal-
lenged with NLRP3 inflammasome activators ( fig. 7 a, b). 
 The oligomerization of SQSTM1 precedes the au-
tophagosome formation  [30] . In THP-1 macrophages, 
CoPP alone induced a robust formation of SQSTM1 
oligomers compared to the diffuse SQSTM1 staining in 
nontreated cells ( fig. 7 c). In addition, in the presence of 
CoPP, ASC rather localized with nuclear DAPI-staining 
whereas ASC staining in nontreated cells appeared most-
ly cytoplasmic. SQSTM1 is degraded in the autophago-
somes, and therefore the amount of intracellular SQSTM1 
reflects the level of autophagosomal degradation, i.e. au-
tophagic flux  [31] . To determine the efficiency of autoph-
agic flux, the degradation of SQSTM1 was studied in hu-
man primary macrophages. In the presence of LPS, the 
intracellular levels of SQSTM1 were increased compared 
to nonactivated cells ( fig. 7 d). In contrast, incubation of 
the human primary macrophages or THP-1 macrophages 
in the presence of CoPP, and to a lesser extent hemin, in-
creased the degradation of SQSTM1 both in nonactivated 
and activated cells ( fig. 7 d, e; online suppl. fig. 4A, B). To 
further study whether CoPP- or hemin-induced deple-
tion of ASC depended on autophagy, autophagic seques-
tration was inhibited with 3-methyl adenine (3-MA), a 
phosphoinositide 3-kinase inhibitor. As expected, the 
treatment of the THP-1 macrophages with 3-MA for 23 
h diminished the ratio of LC3-II to LC3-I (online suppl. 
fig. 4C). Importantly, the treatment with 3-MA reversed 
the CoPP-induced depletion of intracellular ASC in both 
nonactivated and nigericin-activated THP-1 macro-
phages ( fig. 7 f; online suppl. fig. 4D). In conclusion, the 
data above suggest that hemin and CoPP enhance the 
degradation of ASC by increasing the autophagic flux, 
which results in reduced intracellular ASC levels and re-
duced activation of the NLRP3 inflammasome.
 Discussion 
 The activation of the NLRP3 inflammasome and the 
consequent secretion of IL-1β and IL-18 result in a robust 
inflammatory reaction, and thus stringent regulatory 
mechanisms of NLRP3 activation are required. In this 
study, we demonstrate that hemin may act as an impor-
tant negative regulator of the NLRP3 inflammasome in 
macrophages. Pronounced inhibition of secretion of IL-
1β and IL-18 was observed in the presence of hemin or its 
derivative CoPP. Importantly, such an inhibitory effect 
could also be observed in vivo. Thus, the injection of 
CoPP into the peritoneal cavity prior to the activation of 
the NLRP3 inflammasome by MSU crystals attenuated 
peritonitis in mice by inhibiting the secretion of IL-1β, as 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
ity
 o
f H
el
sin
ki 
   
   
   
   
   
   
   
   
   
   
  
12
8.
21
4.
58
.1
08
 - 
2/
17
/2
01
7 
11
:1
1:
40
 A
M
 Nurmi   et al.
 
J Innate Immun 2017;9:65–82
DOI: 10.1159/000448894
78
LPS
ATP
CoPP (μM)
Hemin (μM)
– ––– + + + +
– +–– – + + +
50– – – 50– – –
– ––– 50 – 50 –
Lysate
Actin
LC3-I
LC3-II
CoPP 2 h CoPP 4 hCntr
Nig
CoPP (μM)
+ +––
5– – 5
LC3-I
LC3-II
Lysate
Actin
0
1
2
3
LPS
ATP
CoPP (μM)
Hemin (μM)
– ––– + + + +
– +–– – + + +
50– – – 50– – –
– ––– 50 – 50 –
LC
3 
ra
tio
 (f
ol
d 
ch
an
ge
)
**
2
4
6
Nig
CoPP (μM)
+ +––
5– – 5
LC
3 
ra
tio
 (f
ol
d 
ch
an
ge
)
0
a
c
b
 7 
(For legend see next page.)
Co
lo
r v
er
si
on
 a
va
ila
bl
e 
on
lin
e
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
ity
 o
f H
el
sin
ki 
   
   
   
   
   
   
   
   
   
   
  
12
8.
21
4.
58
.1
08
 - 
2/
17
/2
01
7 
11
:1
1:
40
 A
M
 Hemin and CoPP Inhibit NLRP3 
Activation by Enhancing Autophagy 
J Innate Immun 2017;9:65–82
DOI: 10.1159/000448894
79
3MA
Nig
CoPP (μM)
– ––– +
+ +–– –
5– – 5 –
+ +
– +
5 –
+
+
5
Lysate
Actin
ASC
LPS
ATP
CoPP (μM)
Hemin (μM)
– ––– + + + +
– +–– – + + +
50– – – 50– – –
– ––– 50 – 50 –
Lysate
Actin
SQSTM1
Nig
CoPP (μM)
Hemin (μM)
+ +–– – +
5– 5 –– –
2–– – – 2
SQSTM1
Actin
Lysate
f
d e
well as by modestly reducing leukocyte recruitment into 
the peritoneal cavity ( fig. 2 e, f). 
 In the heme molecule, the iron atom can reversibly 
change its oxidative state  [32] ; in the ferrous (Fe 2+ ) state, 
the molecule is called ‘heme’, and in the ferric (Fe 3+ ) state, 
‘hemin’  [32] . Previous studies have shown that, in the ab-
sence of other inflammasome activators, heme induces ac-
tivation of the NLRP3 inflammasome  [27, 33] . According 
to the results obtained by Dutra et al.  [27] , heme-induced 
processing of pro-IL-1β in vitro requires the presence of 
serum. Somewhat in contrast with these results, hemin 
was shown to ameliorate NLRP3 inflammasome activa-
tion during LPS- and  D -galactosamine-induced liver in-
jury  [34] and sepsis-induced lung injury  [35] in vivo as 
well as LPS-induced NLRP3 inflammasome activation in 
gingival cells in vitro  [36] , by reducing the TLR-induced 
expression of NLRP3 inflammasome components and the 
ROS-dependent inflammasome complex formation. It re-
mains to be elucidated why, under certain conditions, 
heme/hemin functions as an activator of the NLRP3 in-
flammasome, but, in the presence of NLRP3 inflamma-
some activators, exerts inhibitory action. Different exper-
imental settings and the oxidation state of the iron may 
contribute to the variable effects of heme/hemin.
 Activation of the NLRP3 inflammasome requires 2 
separate signals: a priming signal, induced by the activa-
tion of the TLRs, during which the transcription of pro-
IL-1β and NLRP3 are induced and a second signal that is 
followed by the assembly and activation of the inflamma-
some complex  [2] . In this study, macrophages were 
primed with LPS prior to treatment with hemin or CoPP 
and under these conditions, neither hemin nor CoPP had 
any significant inhibitory effect on the expression of  IL1B 
or  NLRP3 ( fig. 3 a, b) or the protein levels of pro-IL-1β, 
 Fig. 7. Induction of autophagy contributes to the degradation of 
ASC.  a ,  d Unprimed or LPS-primed human primary macrophages 
were incubated for 3 h in the presence of CoPP or hemin, and then 
activated with ATP.  b ,  e THP-1 macrophages were incubated for 
3 h in the presence of CoPP or hemin, and thereafter activated with 
nigericin (Nig.).  a Western blot analysis and quantitation of LC3 
(LC3-I 19 kDa and LC3-II 17 kDa) bands of human primary mac-
rophage lysates.  b Western blot analysis and quantitation of LC3 
(LC3-I 19 kDa and LC3-II 17 kDa) bands of THP-1 macrophage 
lysates.  * *  p ≤ 0.01.  a ,  b In the quantitations, the ratio of the inten-
sities of the bands of LC3-I and LC3-II (LC3-II/LC3-I) are ex-
pressed as fold changes compared to the LC3 ratio determined 
from the nontreated cells. Data represent the means ± SD.  c THP-
1 macrophages were incubated in the presence of CoPP for the 
indicated times, and stained for SQSTM1 (green), ASC (red) and 
DNA (blue, DAPI; colors refer to the online version).  d Western 
blot analysis of SQSTM1 (62 kDa) of human primary macrophage 
lysates.  e Western blot analysis of SQSTM1 (62 kDa) of THP-1 
macrophage lysates.  f THP-1 macrophages were first incubated in 
the presence of autophagy inhibitor 3-MA, then for 3 h in the pres-
ence of CoPP, and finally activated with nigericin. Intracellular 
ASC (22 kDa) was assessed from the cell lysates by Western blot 
analysis. The Western blots or immunofluorescence microscopy 
images shown are representative of 3 ( b ), 4 ( a ,  c ,  f ) or 5 ( d ,  e ) in-
dividual experiments.  
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NLRP3 and procaspase-1 ( fig. 3 c, d). This suggests that 
hemin and CoPP did not reduce the priming of the in-
flammasome, but instead interfered with the formation 
or function of the inflammasome complex. In accordance 
with this, hemin and CoPP significantly reduced the for-
mation of inflammasome complexes as reflected by the 
reduced formation of ASC specks ( fig. 6 a, b). NLRP3 re-
ceptor lacks the CARD domain and therefore the adaptor 
protein ASC is vital for the assembly and recruitment of 
procaspase-1 to the inflammasome complex  [2, 6] . The 
reduction of inflammasome complex formation was most 
likely due to the reduced availability of intracellular ASC 
( fig. 6 a, c, d). As the expression of  ASC was not reduced, 
and the secretion of ASC protein was not enhanced in the 
presence of CoPP and hemin (online suppl. fig. 3C;  fig. 6 e, 
f), the reduction in intracellular ASC levels was most like-
ly caused by its increased degradation. 
 Autophagy has been suggested to restrict the activation 
of NLRP3 and AIM2 inflammasomes by targeting inflam-
masome components for degradation in the autophago-
somes  [13] . Several observations suggest that the hemin- 
and CoPP-induced reduction of ASC level was caused by 
increased autolysosomal degradation of ASC. Both hemin 
and CoPP increased the autophagosome formation as re-
flected by increased ratio of LC3-II to LC3-I ( fig. 7 a, b), 
and also enhanced the degradation of autophagosomal 
proteins, as reflected by the reduced levels of SQSTM1 
( fig. 7 d, e), which is degraded in the autophagosomes. Fur-
thermore, CoPP could no longer induce the depletion of 
ASC in the presence of the autophagy inhibitor 3-MA 
( fig. 7 f). Reduced production of mitochondrial ROS could 
have contributed to the inhibitory effect of hemin and 
CoPP. Since hemin and CoPP specifically reduced the ac-
cumulation of mitochondrial ROS, it is conceivable that 
the inhibitory effect of hemin and CoPP was mediated via 
enhanced autophagy that reduced the number of ROS pro-
ducing mitochondria rather than via any HO-1-mediated 
antioxidant effects. Altogether, these findings strongly 
suggest that the induction of autophagy played a key role 
in the inhibition of inflammasome by hemin and CoPP. 
 Hemin has been shown to induce autophagic clear-
ance of mitochondria in bovine endothelial cells and in a 
leukemic erythroblast cell line  [37, 38] ; however, the exact 
mechanism by which hemin and CoPP activate the au-
tophagy in macrophages remains to be elucidated. Sev-
eral lines of evidence suggest that induction of HO-1 en-
zyme could contribute to the activation of autophagy. 
Carchman et al.  [39]  have demonstrated that HO-1 is 
necessary for the induction of autophagy in mouse hepa-
tocytes. Furthermore, the HO-1-mediated degradation of 
heme to carbon monoxide has been shown to increase the 
intracellular level of LC3 protein, along with enhanced 
formation of autophagosomes  [40] . In this study, an en-
zymatic inhibitor of HO-1, stannous mesoporphyrin, at-
tenuated the CoPP-induced inhibition of IL-1β secretion 
( fig. 5 b), suggesting the involvement of HO-1. In addi-
tion, nigericin-induced secretion of IL-1β was enhanced 
in the HO-1-deficient macrophages (online suppl. 
fig. 2K). However, hemin and CoPP inhibited the inflam-
masome activation, also in the peritoneal macrophages of 
HO-1-deficient mice, which argues against the role of 
HO-1. It should be noted that the deletion of  Hmox1 in 
the peritoneal macrophages of HO-1-deficient mice was 
incomplete, and thus it cannot be ruled out that the
residual expression of  Hmox1 in the LysMCre +/– 
HMOX1 fl/fl mouse macrophages was sufficient to medi-
ate the inhibitory effect of hemin and CoPP. In conclu-
sion, it seems that the induction of HO-1 may contribute 
to the inhibitory effect of hemin and CoPP on the secre-
tion of IL-1β and activation of autophagy. 
 The role of heme/hemin in the regulation of NLRP3 
inflammasome activation is intriguing. Despite its pro-
oxidant and proinflammatory properties, in the presence 
of NLRP3 inflammasome activation hemin acts as an in-
hibitor. In numerous pathological conditions, such as se-
vere inflammation and infections, tissue damage en-
hances the release of heme/hemin to the circulation. Re-
ciprocally, to maintain homeostasis, the cytokines re-
leased during inflammation enhance the sequestration of 
heme/hemin to macrophages  [1] . To avoid the excessive 
NLRP3 inflammasome activation caused by inflamma-
some activators generated during inflammation, it is cru-
cial to possess efficient inhibitory mechanisms to restrict 
overwhelming inflammatory reactions. It is possible that 
hemin-induced autophagy has evolved to protect the cell 
from heme- and iron-induced oxidative damage to mi-
tochondria  [38] . However, CoPP and hemin inhibited 
the production of mitochondrial ROS triggered during 
the activation of the NLRP3 inflammasome, which may 
reflect hemin- or CoPP-induced enhancement of mito-
chondrial clearance via autophagy. Accordingly, hemin 
and CoPP may trigger autophagy as an inhibitory feed-
back mechanism to restrict the activation of the NLRP3 
inflammasome by reducing the levels of inflammasome 
components and mitochondrial ROS  [13, 14] . 
 In cryopyrin-associated autoinflammatory diseases, 
dysregulated activation of NLRP3 is directly involved in 
the pathogenesis of the syndromes. Excessive activation 
of the NLRP3 inflammasome has also been implicated in 
other autoinflammatory diseases and, more recently, also 
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in the pathogenesis of gout  [8] and atherosclerosis  [4, 5] . 
Thus, the results of this study could provide a novel ap-
proach, for the treatment of not only difficult and life-
threatening autoinflammatory diseases but also more 
common chronic diseases, in which the activation of the 
NLRP3 inflammasome is involved. 
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